AIC
LLY icon

Argus Investors Counsel’s Eli Lilly LLY Stock Holding History

Argus Investors Counsel’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78M Sell
3,987
-76
-2% -$77.7K 3.68% 5
2026
Q1 		$3.74M Sell
4,063
-8
-0.2% -$8.11K 3.32% 8
2025
Q4 		$4.38M Buy
4,071
+65
+2% +$62.2K 3.49% 5
2025
Q3 		$3.06M Sell
4,006
-778
-16% -$579K 2.43% 13
2025
Q2 		$3.73M Sell
4,784
-40
-0.8% -$31.1K 2.65% 7
2025
Q1 		$3.98M Sell
4,824
-424
-8% -$353K 3.04% 4
2024
Q4 		$4.05M Sell
5,248
-26
-0.5% -$21.5K 2.71% 5
2024
Q3 		$4.67M Sell
5,274
-2,999
-36% -$2.7M 3.05% 4
2024
Q2 		$7.49M Buy
8,273
+692
+9% +$554K 4.6% 2
2024
Q1 		$5.9M Buy
7,581
+740
+11% +$527K 3.62% 2
2023
Q4 		$3.99M Sell
6,841
-927
-12% -$541K 2.56% 6
2023
Q3 		$4.17M Buy
7,768
+60
+0.8% +$30.9K 3.01% 4
2023
Q2 		$3.62M Sell
7,708
-971
-11% -$407K 2.51% 4
2023
Q1 		$2.98M Sell
8,679
-56
-0.6% -$18.9K 2.26% 5
2022
Q4 		$3.2M Sell
8,735
-134
-2% -$47.5K 2.56% 4
2022
Q3 		$2.87M Sell
8,869
-575
-6% -$182K 2.55% 3
2022
Q2 		$3.06M Buy
9,444
+135
+1% +$40.5K 2.26% 3
2022
Q1 		$2.67M Buy
9,309
+874
+10% +$225K 1.7% 14
2021
Q4 		$2.33M Buy
8,435
+804
+11% +$204K 1.4% 24
2021
Q3 		$1.76M Buy
7,631
+594
+8% +$147K 1.15% 50
2021
Q2 		$1.61M Buy
7,037
+741
+12% +$149K 0.66% 51
2021
Q1 		$1.18M Buy
6,296
+709
+13% +$139K 0.48% 52
2020
Q4 		$943K Buy
5,587
+580
+12% +$86.6K 0.41% 56
2020
Q3 		$741K Buy
+5,007
New +$775K 0.31% 61

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Argus Investors Counsel's LLY Position: Q2 2026 in Review

Argus Investors Counsel reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $77.7K and leaving 3,987 shares worth $4.78M. The position accounts for 3.68% of the portfolio, ranked #5.

Argus Investors Counsel first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. The position peaked at $7.49M in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Argus Investors Counsel held 3,987 shares of Eli Lilly worth $4.78M as of Q2 2026.
  • Argus Investors Counsel sold 76 Eli Lilly shares in Q2 2026, an estimated $77.7K.
  • Eli Lilly made up 3.68% of Argus Investors Counsel's portfolio in Q2 2026, its #5 holding.
  • Argus Investors Counsel first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • Argus Investors Counsel's Eli Lilly position peaked at $7.49M in Q2 2024.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Argus Investors Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.